Science DailyEngineers discover geometric underpinnings of T-cell stimulation through precise engineering of T-cell receptor …Science DailyWith the specific knowledge of the geometric parameters underlying T-cell receptor triggering, researchers coul… Continue reading
Miami Herald |
Merck, riding clinical success, eyes cancer immunotherapy lead
BioPharma Dive Merck & Co.’s flagship cancer drug Keytruda surpassed diabetes medicines Januvia and Janumet as the pharma’s top-selling therapeutic franchise in the first quarter, underscoring the rapid sales growth of the immunotherapy over the past year. Sales of … Merck lifts earnings forecast after currency boostFinancial Times |
Miami Herald |
Merck, riding clinical success, eyes cancer immunotherapy lead
BioPharma Dive Merck & Co.’s flagship cancer drug Keytruda surpassed diabetes medicines Januvia and Janumet as the pharma’s top-selling therapeutic franchise in the first quarter, underscoring the rapid sales growth of the immunotherapy over the past year. Sales of … Merck lifts earnings forecast after currency boostFinancial Times |
Scientific American |
UC vs. Harvard: Round 2 in CRISPR gene technology fight
Santa Cruz Sentinel It’s a high stakes showdown over intellectual-property rights between two of the nation’s most prestigious institutions, with perhaps a billion dollars in the balance. While research universities often reach settlements over patent disputes, both sides … All You Need to Know for Round 2 of the CRISPR Patent FightScientific American UC vs. Harvard: Round 2 in CRISPR fightThe Mercury News UC fights for CRISPR patent rights against Broad Institute, Harvard …Daily Californian |
Eureka Times Standard |
UC vs. Harvard: Round 2 in CRISPR gene technology fight
Eureka Times Standard It’s a high stakes showdown over intellectual-property rights between two of the nation’s most prestigious institutions, with perhaps a billion dollars in the balance. While research universities often reach settlements over patent disputes, both sides … |